Rachael C. Hunter
13Patents
6h-index
61Co-inventors
65Inventor score
Filing activity: Mar 19, 2002 → Jul 17, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7763609B2 | Heterocyclic aspartyl protease inhibitors | Human Necessities | 34 | Active |
| US7592348B2 | Heterocyclic aspartyl protease inhibitors | Emerging Cross-Sectional Technologies | 14 | Active |
| US8829036B2 | Heterocyclic aspartyl protease inhibitors | Human Necessities | 7 | Active |
| US8691831B2 | Heterocyclic aspartyl protease inhibitors | Human Necessities | 7 | Active |
| US8691833B2 | Heterocyclic aspartyl protease inhibitors | Human Necessities | 7 | Active |
| US7700603B2 | Heterocyclic aspartyl protease inhibitors | Chemistry; Metallurgy | 6 | Active |
| US6887889B2 | Aryl and biaryl piperdines with MCH modulatory activity | Chemistry; Metallurgy | 4 | Expired |
| US8242112B2 | Heterocyclic aspartyl protease inhibitors | Chemistry; Metallurgy | 2 | Active |
| US8471005B2 | Pyrrolotriazines as ALK and JAK2 inhibitors | Human Necessities | 1 | Active |
| US7511146B2 | 2-substituted benzimidazole piperidines analogs as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders | Chemistry; Metallurgy | 0 | Expired |
| US7034056B2 | Aryl and biaryl compounds having MCH modulatory activity | Chemistry; Metallurgy | 0 | Expired |
| US8178513B2 | Heterocyclic aspartyl protease inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
| US8778980B2 | Heterocyclic aspartyl protease inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.